Pages that link to "Q73834345"

The following pages link to Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone (Q73834345):

Displaying 31 items.

• A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates (Q26786354) (← links)
• Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients (Q29364500) (← links)
• Serotonergic hallucinogens as translational models relevant to schizophrenia (Q30427074) (← links)
• Reduced expression of nogo-a leads to motivational deficits in rats (Q30443849) (← links)
• Is the acute NMDA receptor hypofunction a valid model of schizophrenia? (Q30459655) (← links)
• Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. (Q30524246) (← links)
• A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia (Q30619534) (← links)
• Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions? (Q30630506) (← links)
• Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults (Q33478744) (← links)
• Use of positron emission tomography in analysing receptor function in vivo (Q34232401) (← links)
• Genetic labeling reveals novel cellular targets of schizophrenia susceptibility gene: distribution of GABA and non-GABA ErbB4-positive cells in adult mouse brain. (Q34268994) (← links)
• Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys. (Q34379738) (← links)
• 5-HT2A receptor density is decreased in the at-risk mental state (Q34694260) (← links)
• The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders (Q34897526) (← links)
• Positron emission tomography and single photon emission CT molecular imaging in schizophrenia (Q35692963) (← links)
• Htr2a Expression Responds Rapidly to Environmental Stimuli in an Egr3-Dependent Manner. (Q36047803) (← links)
• Neuroreceptor imaging in psychiatry: theory and applications. (Q36314030) (← links)
• Alterations of serotonin transmission in schizophrenia (Q36756370) (← links)
• From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments (Q36872150) (← links)
• Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. (Q36955877) (← links)
• How have developments in molecular imaging techniques furthered schizophrenia research? (Q37829639) (← links)
• Neurochemical Imaging in Schizophrenia (Q37839935) (← links)
• Postmortem studies in schizophrenia. (Q38578521) (← links)
• Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112 (Q39991406) (← links)
• Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans (Q40207601) (← links)
• A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene (Q40594390) (← links)
• The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. (Q44645827) (← links)
• Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity (Q44652896) (← links)
• Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium (Q44715726) (← links)
• Animal Models of Schizophrenia (Q83396618) (← links)
• D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients (Q92929001) (← links)